Concomitant drug-and infection-induced antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis with multispecific ANCA

Medical Principles and Practice

Volumn 21, Issue 5, 2012, Pages 488-491

  Kontic, Milica ^a   Radovanovic, Sanja ^a   Nikolic, Milos ^a   Bonaci Nikolic, Branka ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Antineutrophil cytoplasmic autoantibodies; Bactericidal permeability increasing protein; Drug induced vasculitis; Propylthiouracil; Tuberculosis

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; ELASTASE; ETHAMBUTOL; ISONIAZID; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; THIAMAZOLE;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; LUNG CAVITATION; MEDICAL HISTORY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PURPURA; SPUTUM EXAMINATION; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; HYPERTHYROIDISM; PROPYLTHIOURACIL; TUBERCULOSIS, PULMONARY; VASCULITIS;

EID: 84865009842     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000337944     Document Type: Article

References (10)

1. Jennette JC, Falk RJ: Small-vessels vasculitis. N Engl J Med 1997; 337:1512-1523.
2. Csernok E, Lamprecht P, Gross WL: Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cyto-plasmic antibodies and vasculitis. Curr Opin Rheumatol 2010; 22:43-48.
3. Sherkat R, Mostafavizadeh K, Zeydabadi L, Shoaei P, Rostami S: Antineutrophil cyto-plasmic antibodies in patients with pulmonary tuberculosis. Iran J Immunol 2011; 8: 52-57.
4. Faruqi S, Kastelik JA, McGivern DV: Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA. Eur J Intern Med 2008; 19: 216-218.
5. Aloush V, Litinsky I, Caspi D, Elkayam O: Propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management. Semin Arthritis Rheum 2006; 36:4-9.
6. Schmitt WH, van der Woude FJ: Clinical applications of antineutrophil cytoplasmic antibody testing. Curr Opin Rheumatol 2004; 16: 9-17.
7. Bonaci-Nikolic B, Andrejevic S, Pavlovic M, Dimcic Z, Ivanovic B, Nikolic M: Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to protein-ase 3 and myeloperoxidase: diagnostic and therapeutic challenge. Clin Rheumatol 2010; 29:893-904.
8. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M: Antineutrophil cyto-plasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 2005; 7: R1072-R1081.
9. Esquivel-Valerio JA, Flores-Suárez LF, Rodríguez-Amado J, Garza-Elizondo MA, Rendón A, Salinas-Carmona MC: Antineu-trophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation. Clin Exp R heumatol 2010; 28: 35-39.
10. Yang JJ, Tuttle RH, Hogan SL, Taylor JG, Phillips BD, Falk RJ, Jennette JC: Target antigens for anti-neutrophil cytoplasmic auto-antibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin Exp Immunol 2000; 121: 165-172.